223. Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis (TBM) in Maharaj Nakorn Chiang Mai Hospital
Session: Poster Abstract Session: Diagnostics: Mycobacteriology
Thursday, October 27, 2016
Room: Poster Hall
Posters
  • Poster-223 (IDweek 2016).pdf (629.9 kB)
  • Background:

    Early diagnosis and treatment of tuberculous meningitis (TBM) are crucial steps to reduce morbidity and mortality. Recommendation of using Xpert MTB/RIF assay to diagnose pulmonary TB, pediatrics TB, extrapulmonary TB and rifampicin resistance was made by WHO. However, the data of accuracy in diagnosis of TBM is still lacking. This study aimed to find out the diagnostic performance of Xpert MTB/RIF assay for the diagnosis of tuberculous meningitis.

    Methods:

    A prospective cohort study was conducted at Maharaj Nakorn Chiang Mai Hospital, Thailand. Patients who were ≥15 years old and had subacute lymphocytic meningitis were included.

    Results:

    Fifty patients were included for analysis. Using MGIT TB culture as a reference gold standard, Xpert MTB/RIF assay the sensitivity and specificity were 80% (95% CI=, 44.39%, 97.48%) and 97.5% (95% CI, 86.84%, 99.94%), significantly higher sensitivity (𝑝<0.001) than conventional staining. There was a good concordance between Xpert MTB/RIF assay and MGIT TB culture with 94% agreement (p < 0.001) and kappa of 0.805 (95% CI, 0.593, 1.000).Sensitivity and specificity of the TBM score (≥ 6) compared to the CSF TB culture were 100% and 24.4%, respectively. Twelve TBM patients received treatment but only 10 patients had CSF culture positive for TB, and the agreement between the Xpert MTB/RIF assay versus TBM treatment was 94% (p < 0.001), and the kappa score was 0.82 (95% CI, 0.626, 1.000). Using a TBM score at cut-point of 6, and then the Xpert MTB/RIF assay as the sequential testing, there was an improvement in specificity from 97.5% to 98.13%. No statistical difference of diagnostic performance was found between HIV and non-HIV infected groups. No discordance of rifampin resistance between centrifuged CSF Xpert MTB/RIF assay and conventional drug susceptibility testing.

    Conclusion:

    Centrifuged CSF Xpert MTB/RIF assay was a rapid test todetect M. tuberculosis complex from CSF specimens with high sensitivity and specificity. The TBM scoring system had a very high sensitivity and negative predictive value, but low specificity. This could be used as a screening test for TBM patients before usinga more specific diagnosis test. This sequential testing may be useful as a diagnosis algorithm for rapid diagnosis of TBM.

    Poramed Winichakoon, MD1, Parichat Salee, MD, MHS1, Nontakan Nuntachit, MD1, Quanhathai Kaewpoowat, MD2, Romanee Chaiwarith, MD, MHS1 and Khuanchai Supparatpinyo, MD2, (1)Internal Medicine, Chiang Mai University, Chiang Mai, Thailand, (2)Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand

    Disclosures:

    P. Winichakoon, None

    P. Salee, None

    N. Nuntachit, None

    Q. Kaewpoowat, None

    R. Chaiwarith, None

    K. Supparatpinyo, None

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.